MétaCan
Menu
Back to cohort
Record W4404731501 · doi:10.1038/s41380-024-02800-5

Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies

2024· review· en· W4404731501 on OpenAlexaff
Michel Sabé, Adi Sulstarova, Alban Glangetas, Marco De Pieri, Luc Mallet, Logos Curtis, Hélène Richard-Lepouriel, Louise Penzenstadler, Federico Seragnoli, Gabriel Thorens, Daniele Zullino, Katrin H. Preller, Kerem Böge, Stefan Leucht, Christoph U. Correll, Marco Solmi, Stefan Kaiser, Matthias Kirschner

Bibliographic record

VenueMolecular Psychiatry · 2024
Typereview
Languageen
FieldPsychology
TopicPsychedelics and Drug Studies
Canadian institutionsOttawa HospitalUniversity of Ottawa
FundersAllerganSeqirusSun PharmaH. Lundbeck A/SUniversité de GenèveTeva Pharmaceutical IndustriesHeffter Research InstituteNovo NordiskMitsubishi Tanabe Pharma CorporationQuantICBiogenSK Life ScienceGedeon RichterSunovionMylan
KeywordsPsychosisSchizophrenia (object-oriented programming)Meta-analysisPsychiatryRandomized controlled trialSystematic reviewPopulationMedicinePsychologyClinical psychologyIncidence (geometry)PsilocybinMEDLINEHallucinogenInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Persons with schizophrenia are excluded from psychedelic-assisted therapy due to concerns about the risk of triggering or worsening psychosis. However, there is limited meta-analytic data on the risk of psychedelic-induced psychosis in individuals with pre-existing psychotic disorders. METHODS: We conducted a systematic review, meta-analysis, and overview of reviews to assess the incidence of psychedelic-induced psychosis and symptom exacerbation in schizophrenia. Our pre-registered protocol (CRD42023399591) covered: LSD, psilocybin, mescaline, DMT, and MDMA, using data from Embase, PubMed, PsyARTICLES, PsyINFO, and trial registries up to November 2023. A random-effects model was used to calculate psychosis incidence, with standardized assessments of study quality. RESULTS: From 131 publications, we analyzed 14 systematic reviews, 20 reviews, 35 randomized-controlled trials (RCTs), 10 case-control studies, 30 uncontrolled trials (UCTs), and 22 cohort studies, most of which were low quality. Meta-analysis of nine studies showed an incidence of psychedelic-induced psychosis at 0.002% in population studies, 0.2% in UCTs, and 0.6% in RCTs. In UCTs including individuals with schizophrenia, 3.8% developed long-lasting psychotic symptoms. Of those with psychedelic-induced psychosis, 13.1% later developed schizophrenia. Sensitivity analyses confirmed the results. CONCLUSION: In summary, the reviewed evidence suggests that schizophrenia might not be a definite exclusion criterion for clinical trials exploring safety and efficacy of psychedelics for treatment-resistant depression and negative symptoms. However, given the low quality and limited number of studies, more high-quality research is needed, and a conservative approach is recommended until further data is available.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.053
metaresearch head score (Gemma)0.120
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.053
Threshold uncertainty score0.278

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0530.120
Meta-epidemiology (narrow)0.0040.003
Meta-epidemiology (broad)0.0250.031
Bibliometrics0.0170.014
Science and technology studies0.0010.002
Scholarly communication0.0060.004
Open science0.0030.003
Research integrity0.0030.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.729
GPT teacher head0.578
Teacher spread0.151 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations38
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueMolecular PsychiatrySame topicPsychedelics and Drug StudiesFrench-language works237,207